Upregulation of transient receptor potential melastatin 4 (TRPM4) in ventricular fibroblasts from heart failure patients.

Upregulation of transient receptor potential melastatin 4 (TRPM4) in ventricular fibroblasts from heart failure patients.
复制标题

DOI:
10.1007/s00424-021-02525-2
复制
发表时间:
2021-03
期刊:
Pflugers Archiv : European journal of physiology
影响因子:
--
通讯作者:
Yue L
Yue L
中科院分区:
其他
文献类型:
--
作者:
Feng J;Zong P;Yan J;Yue Z;Li X;Smith C;Ai X;Yue L

文献摘要

参考文献

被引文献

相似文献

The transient receptor potential melastatin 4 (TRPM4) is a Ca2+-activated nonselective monovalent cation channel belonging to the TRP channel superfamily. TRPM4 is widely expressed in various tissues and most abundantly expressed in the heart. TRPM4 plays a critical role in cardiac conduction. Patients carrying a gain-of-function or loss-of-function mutation of TRPM4 display impaired cardiac conduction. Knockout or over-expression of TRPM4 in mice recapitulates conduction defects in patients. Moreover, recent studies have indicated that TRPM4 plays a role in hypertrophy and heart failure. Whereas the role of TRPM4 mediated by cardiac myocytes has been well investigated, little is known about TRPM4 and its role in cardiac fibroblasts. Here we show that in human left ventricular fibroblasts, TRPM4 exhibits typical Ca2+-activation characteristics, linear current–voltage (I–V) relation, and monovalent permeability. TRPM4 currents recorded in fibroblasts from heart failure patients (HF) are more than 2-fold bigger than those from control individuals (CTL). The enhanced functional TRPM4 in HF is not resulted from changed channel properties, as TRPM4 currents from both HF and CTL fibroblasts demonstrate similar sensitivity to intracellular calcium activation and extracellular 9-phenanthrol (9-phen) blockade. Consistent with enhanced TRPM4 activity, the protein level of TRPM4 is about 2-fold higher in HF than that of CTL hearts. Moreover, TRPM4 current in CTL fibroblasts is increased after 24 hours of TGFβ1 treatment, implying that TRPM4 in vivo may be upregulated by fibrogenesis promotor TGFβ1. The upregulated TRPM4 in HF fibroblasts suggests that TRPM4 may play a role in cardiac fibrogenesis under various pathological conditions.
DOI: 10.1007/s00424-019-02326-8
发表时间: 2019-10-29
影响因子: 4.5
作者:
Chen, Bo;Gao, Yahui;Liao, Ping
通讯作者: Liao, Ping
DOI: 10.1038/ni.1648
发表时间: 2008-10
期刊: Nature immunology
影响因子: 30.5
作者:
通讯作者: --
DOI: 10.1113/jphysiol.2012.233593
发表时间: 2012-09-01
影响因子: 5.5
作者:
Chatelier, Aurelien;Mercier, Aurelie;Faivre, Jean Francois
通讯作者: Faivre, Jean Francois
DOI: 10.1161/circresaha.109.206771
发表时间: 2010-03-19
影响因子: 20.1
作者:
Du J;Xie J;Zhang Z;Tsujikawa H;Fusco D;Silverman D;Liang B;Yue L
通讯作者: Yue L
DOI: 10.1016/j.ceca.2006.04.032
发表时间: 2007-01-01
期刊: CELL CALCIUM
影响因子: 4
作者:
Cheng, Henrique;Beck, Andreas;Penner, Reinhold
通讯作者: Penner, Reinhold